Hi
buy this stock at 4.450
target at 5.50
stop at 3.97
news :
ATLANTA, Nov 03, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corautus Genetics Inc. (VEGF), a clinical stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track designation to Corautus for Vascular Endothelial Growth Factor 2 ("VEGF-2") for the treatment of severe angina associated with cardiovascular disease. ...
Techicals :
Candelstick : white Marabozu
Volume : high volume
Chart pattern : ascending triangle breakout and good support at 0.400
Indicators : Well oriented...MACD > 0 and RSI > 50 and adx < 15 AND +DI CROSS over -DI and ROC > 0 AND cHAIKIN oSCILLATOR > 0 -> signals...
This stock is very thinly traded...the "high volume" on Friday was only 72,000 shares.
This kinda reminds me of a stock wiseman wouldve picked.
Perhaps more news on the drug is coming...I'd just be careful.
There's plenty of volume today. They are involved some sort of talks with a private bio-tech